United States · FDA National Drug Code directory
CYCLOBENZAPRINE HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68788-8471_5ca0afab-45a0-4a76-84b1-a2a3e6728867
- Product NDC
- 68788-8471
- Form
- TABLET, FILM COATED
- Composition / generic term
- cyclobenzaprine hydrochloride
- Labeler
- Preferred Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230629
- Source listing expiry
- 20271231
Source-listed ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 20 TABLET, FILM COATED in 1 BOTTLE (68788-8471-2) · 68788-8471-2
- 30 TABLET, FILM COATED in 1 BOTTLE (68788-8471-3) · 68788-8471-3
- 60 TABLET, FILM COATED in 1 BOTTLE (68788-8471-6) · 68788-8471-6
- 120 TABLET, FILM COATED in 1 BOTTLE (68788-8471-8) · 68788-8471-8
- 90 TABLET, FILM COATED in 1 BOTTLE (68788-8471-9) · 68788-8471-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →